Madrigal Pharmaceuticals Reports 2018 Fourth Quarter and Full Year Financial Results and Highlights

Go back to Madrigal Pharmaceuticals Reports 2018 Fourth Quarter and Full Year Financial Results and Highlights
(NASDAQ: MDGL) Delayed: 528.10 +13.71 (2.67%)
Previous Close $514.39    52 Week High $18.24 
Open $512.34    52 Week Low $6.60 
Day High $529.73    P/E N/A 
Day Low $507.60    EPS $0.00 
Volume 222,406